share_log
Breakings ·  Sep 10 19:30
Arrowhead Pharmaceuticals Inc - to Submit New Drug Application for Plozasiran by Year-End 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment